Tufts Report: Orphan Drugs Take an Average of 15 Years to Launch

Drug Industry Daily
A A
Orphan drug development takes 18 percent longer to reach the product launch stage than new drugs across the board, according to a new analysis from the Tufts Center for the Study of Drug Development.

To View This Article:

Login

Subscribe To Drug Industry Daily